Mark C. McKenna - 05 Jun 2024 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Director
Signature
/s/ Matthew Batters, as attorney-in-fact for Mark McKenna
Issuer symbol
APGE
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
07 Jun 2024, 20:05:08 UTC
Previous filing
08 Feb 2024
Next filing
11 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Stock Option (Right to Buy) Award $0 +10,370 $0.000000 10,370 05 Jun 2024 Common Stock 10,370 $43.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 10,370 shares of the Issuer's common stock and will vest on the one-year anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer on such vesting date.